Tag-Archive for ◊ medical device careers ◊

• Wednesday, February 05th, 2014

Like little factories, cells metabolize raw materials and convert them into chemical compounds. Biotechnologists take advantage of this ability, using microorganisms to produce pharmaceuticals and biofuels. To boost output to an industrial scale and create new types of chemicals, biotechnologists manipulate the microorganisms’ natural metabolism, often by “overexpressing” certain genes in the cell. But such […]

• Tuesday, February 04th, 2014

A lineup of medical device entrepreneurs are working with doctors in UCSF’s Department of Surgery and bioengineering graduate students to honor a longtime colleague by shaping life-saving products from fresh ideas. The Rosenman Institute, a new organization set up under the umbrella of the University of California’s QB3 institute, launched this month with some 20 […]

• Tuesday, February 04th, 2014

Bard Announces $500 Million Share Repurchase Authorization MURRAY HILL, N.J.–(BUSINESS WIRE)–C. R. Bard, Inc. (NYSE:BCR) today announced that its Board of Directors has authorized the repurchase of up to $500 million of the company’s common stock. This new authorization is in addition to the approximately $55 million remaining under the Company’s prior authorization. Share repurchases […]

• Monday, February 03rd, 2014

Melanoma Diagnostic Provider, MELA Sciences, to Raise $12.45 Million in Private Placement to Institutional Investors and MELA Sciences Directors MELA Sciences, Inc. (NASDAQ: MELA), (the Company) developer of MelaFind, an FDA approved optical diagnostic device that assists dermatologists in melanoma diagnosis, today announced it has entered into definitive agreements with institutional investors and management for […]

• Monday, February 03rd, 2014

Wright Medical Group, Inc. Announces Acquisition of Solana Surgical, LLC and Entry into Definitive Agreement to Acquire OrthoPro, LLC MEMPHIS, Tenn.–(BUSINESS WIRE)–Wright Medical Group, Inc. (NASDAQ: WMGI) today announced it has acquired Solana Surgical, LLC (Solana) and entered into a definitive agreement to acquire OrthoPro, LLC (OrthoPro), both privately held high growth extremity companies. The […]

• Wednesday, January 29th, 2014

Mountain View, Calif. –January 28, 2014 23andMe, the leading personal genetics company, has participated in the first ever genome-wide association study of the combined asthma-with-hay fever phenotype. Led by researchers at the QIMR Berghofer Medical Research Institute, the study identified 11 independent genetic markers associated with the development of asthma-with-hay fever, including two associations reaching […]

• Wednesday, January 29th, 2014

Negative Pressure Wound Therapy helps reduce infections and other surgical complications, according to a clinical review published by a Smith & Nephew-funded expert panel. Smith & Nephew (FTSE:SN, NYSE:SNN) touted the outcomes of a clinical study review, reporting that Negative Pressure Wound Therapy proved effective in reducing complications when applied to surgical wounds for a few […]

• Wednesday, January 29th, 2014

Hospital equipment maker Hill-Rom (Batesville, IN) plans on cutting approximately 350 workers, or 5% of its global workforce, to save roughly $30 million annually. The restructuring efforts include a downsizing of the firm’s European manufacturing capacity and the closure of one facility there. In addition, Hill-Rom will streamline operations in both the continent and the […]

• Tuesday, January 28th, 2014

St. Jude Medical Announces Organizational and Executive Leadership Changes ST. PAUL, Minn.–(BUSINESS WIRE)– St. Jude Medical, Inc. (STJ), a global medical device company, today announced organizational and leadership changes designed to improve growth. The company will integrate its two operating divisions into one integrated research and development organization, and will combine manufacturing and supply chain […]

• Friday, January 24th, 2014

Johnson & Johnson subsidiary Codman Neuro’s recall of its Trufill n-BCA liquid embolic system gets labeled as a Class I measure by the FDA. Codman Neuro, a division of Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes, said the FDA labeled its Trufill n-BCA liquid embolic system recall as Class I, the federal watchdog agency’s highest-risk classification. The […]